46,000 Shares in Option Care Health, Inc. $OPCH Bought by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 1st quarter, Holdings Channel.com reports. The institutional investor bought 46,000 shares of the company’s stock, valued at approximately $1,238,000.

Other hedge funds also recently added to or reduced their stakes in the company. Blue Trust Inc. boosted its holdings in shares of Option Care Health by 9.9% during the first quarter. Blue Trust Inc. now owns 10,100 shares of the company’s stock valued at $272,000 after acquiring an additional 913 shares during the period. OP Asset Management Ltd bought a new position in shares of Option Care Health during the first quarter worth about $591,000. Brookstone Capital Management acquired a new stake in shares of Option Care Health in the 1st quarter worth about $634,000. Sheets Smith Wealth Management increased its holdings in shares of Option Care Health by 18.6% in the 1st quarter. Sheets Smith Wealth Management now owns 31,030 shares of the company’s stock worth $835,000 after acquiring an additional 4,863 shares during the period. Finally, Pacer Advisors Inc. lifted its position in Option Care Health by 97.1% in the 4th quarter. Pacer Advisors Inc. now owns 42,121 shares of the company’s stock valued at $1,342,000 after purchasing an additional 20,751 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the company’s stock in a transaction on Monday, May 4th. The shares were purchased at an average cost of $21.41 per share, for a total transaction of $783,820.10. Following the completion of the transaction, the director owned 450,000 shares in the company, valued at $9,634,500. The trade was a 8.86% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John Charles Rademacher purchased 12,500 shares of the business’s stock in a transaction on Monday, May 4th. The stock was acquired at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the acquisition, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. The trade was a 1.83% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 73,264 shares of company stock valued at $1,548,316 over the last 90 days. 1.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have issued reports on OPCH. JPMorgan Chase & Co. reduced their target price on shares of Option Care Health from $40.00 to $33.00 and set an “overweight” rating for the company in a research note on Monday, May 4th. UBS Group restated a “buy” rating on shares of Option Care Health in a research note on Tuesday, June 16th. Weiss Ratings cut Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Monday, May 11th. Zacks Research downgraded Option Care Health from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. Finally, Morgan Stanley set a $28.00 price objective on Option Care Health in a report on Wednesday, May 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Stock Performance

Option Care Health stock opened at $21.90 on Friday. Option Care Health, Inc. has a 12-month low of $18.01 and a 12-month high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The stock has a market capitalization of $3.44 billion, a PE ratio of 16.98, a price-to-earnings-growth ratio of 1.22 and a beta of 0.65. The firm has a 50 day simple moving average of $21.67 and a 200-day simple moving average of $28.26.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Thursday, April 30th. The company reported $0.40 earnings per share for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.40 earnings per share. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.